BCOR |
Q6W2J9
|
BCL6 corepressor
|
|
1.00 |
0.471 |
0.808 |
2
|
BRIP1 |
Q9BX63
|
BRCA1 interacting protein C-terminal helicase 1
|
Enzyme
|
6.2E-17 |
0.507 |
0.731 |
6
|
CBL |
P22681
|
Cbl proto-oncogene
|
Enzyme
|
6.1E-04 |
0.527 |
0.769 |
4
|
CBLB |
Q13191
|
Cbl proto-oncogene B
|
Enzyme
|
1.00 |
0.691 |
0.423 |
1
|
CBLC |
Q9ULV8
|
Cbl proto-oncogene C
|
Enzyme
|
4.2E-11 |
0.821 |
0.192 |
1
|
CEBPA |
P49715
|
CCAAT enhancer binding protein alpha
|
Transcription factor
|
0.55 |
0.496 |
0.692 |
2
|
CSF3R |
Q99062
|
colony stimulating factor 3 receptor
|
Signaling
|
1.5E-10 |
0.550 |
0.692 |
7
|
CREBBP |
Q92793
|
CREB binding protein
|
|
1.00 |
0.428 |
0.808 |
4
|
CUX1 |
P39880 Q13948
|
cut like homeobox 1
|
Transcription factor
|
1.00 |
0.465 |
0.846 |
9
|
DNMT3A |
Q9Y6K1
|
DNA methyltransferase 3 alpha
|
|
7.4E-39 |
0.445 |
0.846 |
1
|
EP300 |
Q09472
|
E1A binding protein p300
|
|
1.00 |
0.459 |
0.846 |
12
|
ETV6 |
P41212
|
ETS variant transcription factor 6
|
Transcription factor
|
0.97 |
0.477 |
0.731 |
1
|
FANCA |
O15360
|
FA complementation group A
|
|
1.6E-68 |
0.505 |
0.731 |
3
|
FANCC |
Q00597
|
FA complementation group C
|
|
2.8E-13 |
0.507 |
0.808 |
8
|
FANCD2 |
Q9BXW9
|
FA complementation group D2
|
|
1.1E-30 |
0.479 |
0.885 |
2
|
FANCE |
Q9HB96
|
FA complementation group E
|
|
1.5E-06 |
0.553 |
0.808 |
2
|
FANCF |
Q9NPI8
|
FA complementation group F
|
|
0.46 |
0.535 |
0.731 |
2
|
FANCG |
O15287
|
FA complementation group G
|
|
2.5E-14 |
0.556 |
0.769 |
2
|
FLT3 |
P36888
|
fms related receptor tyrosine kinase 3
|
Kinase
|
0.61 |
0.462 |
0.654 |
2
|
GATA2 |
P23769
|
GATA binding protein 2
|
|
0.98 |
0.496 |
0.654 |
1
|
HRAS |
P01112
|
HRas proto-oncogene, GTPase
|
Enzyme modulator
|
8.0E-02 |
0.378 |
0.885 |
29
|
IDH1 |
O75874
|
isocitrate dehydrogenase (NADP(+)) 1
|
|
2.6E-12 |
0.424 |
0.808 |
9
|
IDH2 |
P48735
|
isocitrate dehydrogenase (NADP(+)) 2
|
|
0.88 |
0.434 |
0.808 |
5
|
JAK1 |
P23458
|
Janus kinase 1
|
Kinase
|
1.00 |
0.474 |
0.769 |
3
|